Boston Scientific is a Buy with a $109 target and 14% upside from strong demand, Q3 beats, raised FY25 guidance, and growth ...
A weak battery is only part of the story. Lost security updates and quietly breaking apps show when keeping your phone costs ...
Instead of reacting to massive wildfires, a new system developed by the Israeli company FireDome, a beneficiary of support ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback